Amonafide+Cytarabine may not be effective for secondary acute myeloid leukemia, according to ACCEDE trial data
By Jonathan S. Batchelor
Advertisement
Articles by By Jonathan S. Batchelor
High doses of methotrexate increases EFS for children and young adults
Advertisement
Latest Updated Articles
High-Dose Methotrexate Better for ALLPublished: June 4th 2011 | Updated:
Amonafide Plus Cytarabine Fails To Meet Primary EndpointPublished: June 4th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5